×

Modulation of apolipoprotein (a) expression

  • US 7,741,305 B2
  • Filed: 07/30/2007
  • Issued: 06/22/2010
  • Est. Priority Date: 08/07/2001
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method comprising administering to a human an antisense compound comprising an antisense oligonucleotide 12 to 30 nucleobases in length wherein the antisense oligonucleotide specifically hybridizes to at least 8 consecutive nucleotides selected from nucleotides 13711-13750 of SEQ ID NO:

  • 4.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×